Francesca Vastola

774 total citations
14 papers, 491 citations indexed

About

Francesca Vastola is a scholar working on Genetics, Pulmonary and Respiratory Medicine and Epidemiology. According to data from OpenAlex, Francesca Vastola has authored 14 papers receiving a total of 491 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Genetics, 10 papers in Pulmonary and Respiratory Medicine and 5 papers in Epidemiology. Recurrent topics in Francesca Vastola's work include Glioma Diagnosis and Treatment (12 papers), Brain Metastases and Treatment (9 papers) and Meningioma and schwannoma management (5 papers). Francesca Vastola is often cited by papers focused on Glioma Diagnosis and Treatment (12 papers), Brain Metastases and Treatment (9 papers) and Meningioma and schwannoma management (5 papers). Francesca Vastola collaborates with scholars based in Italy. Francesca Vastola's co-authors include Alba A. Brandes, Umberto Basso, S. Monfardini, Mario Ermani, Franco Berti, Antonino Rotilio, Michele Reni, Giovanna Cavallo, Renato Scienza and Marina Paola Gardiman and has published in prestigious journals such as Journal of Clinical Oncology, Cancer and International Journal of Radiation Oncology*Biology*Physics.

In The Last Decade

Francesca Vastola

13 papers receiving 472 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Francesca Vastola Italy 9 421 238 149 109 89 14 491
T. Gorlia Belgium 8 281 0.7× 161 0.7× 66 0.4× 93 0.9× 77 0.9× 15 367
J. Curschmann Switzerland 4 331 0.8× 172 0.7× 115 0.8× 67 0.6× 57 0.6× 6 431
Clemens Seidel Germany 12 412 1.0× 201 0.8× 137 0.9× 111 1.0× 115 1.3× 60 559
Irene van Heuvel Netherlands 9 450 1.1× 210 0.9× 117 0.8× 113 1.0× 114 1.3× 12 506
Roy Torcuator United States 8 451 1.1× 233 1.0× 71 0.5× 114 1.0× 105 1.2× 8 585
Richard Zuniga United States 6 360 0.9× 211 0.9× 57 0.4× 121 1.1× 85 1.0× 16 498
L. E. Abrey United States 6 386 0.9× 169 0.7× 55 0.4× 144 1.3× 72 0.8× 6 466
Ralf Ketter Germany 12 286 0.7× 130 0.5× 193 1.3× 97 0.9× 119 1.3× 25 515
P.K. Sneed United States 11 331 0.8× 302 1.3× 178 1.2× 103 0.9× 223 2.5× 32 702
Jean-Yves Delattre France 10 240 0.6× 177 0.7× 81 0.5× 49 0.4× 34 0.4× 11 306

Countries citing papers authored by Francesca Vastola

Since Specialization
Citations

This map shows the geographic impact of Francesca Vastola's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Francesca Vastola with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Francesca Vastola more than expected).

Fields of papers citing papers by Francesca Vastola

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Francesca Vastola. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Francesca Vastola. The network helps show where Francesca Vastola may publish in the future.

Co-authorship network of co-authors of Francesca Vastola

This figure shows the co-authorship network connecting the top 25 collaborators of Francesca Vastola. A scholar is included among the top collaborators of Francesca Vastola based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Francesca Vastola. Francesca Vastola is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

14 of 14 papers shown
1.
Brandes, Alba A., Alicia Tosoni, Francesca Vastola, et al.. (2004). Efficacy and feasibility of standard procarbazine, lomustine, and vincristine chemotherapy in anaplastic oligodendroglioma and oligoastrocytoma recurrent after radiotherapy. Cancer. 101(9). 2079–2085. 34 indexed citations
2.
Reni, Michele, Alba A. Brandes, V. Vavassori, et al.. (2004). A multicenter study of the prognosis and treatment of adult brain ependymal tumors. Cancer. 100(6). 1221–1229. 77 indexed citations
3.
Brandes, Alba A., Umberto Basso, Michele Reni, et al.. (2004). First-Line Chemotherapy With Cisplatin Plus Fractionated Temozolomide in Recurrent Glioblastoma Multiforme: A Phase II Study of the Gruppo Italiano Cooperativo di Neuro-Oncologia. Journal of Clinical Oncology. 22(9). 1598–1604. 93 indexed citations
4.
Brandes, Alba A., Francesca Vastola, Umberto Basso, et al.. (2003). A prospective study on glioblastoma in the elderly. Cancer. 97(3). 657–662. 132 indexed citations
5.
Brandes, Alba A., Umberto Basso, Francesca Vastola, et al.. (2003). Carboplatin and teniposide as third-line chemotherapy in patients with recurrent oligodendroglioma or oligoastrocytoma: a phase II study. Annals of Oncology. 14(12). 1727–1731. 24 indexed citations
6.
Lumachi, Franco, Mario Ermani, Alba A. Brandes, et al.. (2003). Prevalence of breast cancer in women with breast complaints. Retrospective analysis in a population of symptomatic patients.. PubMed. 22(6B). 3777–80. 4 indexed citations
7.
Brandes, Alba A., Mario Ermani, Pietro Amistà, et al.. (2003). The treatment of adults with medulloblastoma: a prospective study. International Journal of Radiation Oncology*Biology*Physics. 57(3). 755–761. 57 indexed citations
8.
Basso, Umberto, Alicia Tosoni, Francesca Vastola, & Alba A. Brandes. (2003). Guidelines for the treatment of malignant gliomas in elderly patients.. PubMed. 13(1). 46–60. 1 indexed citations
9.
Basso, Umberto, Michele Reni, Francesca Vastola, et al.. (2003). 309 First line temozolomide (tmz) in recurrent or progressive oligodendroglioma. a phase II study (Gruppo Italiano cooperativo neuro-oncologia). European Journal of Cancer Supplements. 1(5). S95–S95. 2 indexed citations
10.
Basso, Umberto, Mario Ermani, Francesca Vastola, & Alba A. Brandes. (2002). Non-cytotoxic Therapies for Malignant Gliomas. Journal of Neuro-Oncology. 58(1). 57–69. 21 indexed citations
11.
Brandes, Alba A., Francesca Vastola, & Umberto Basso. (2002). Controversies in the therapy of low-grade glioma: when and how to treat. Expert Review of Anticancer Therapy. 2(5). 529–536. 3 indexed citations
12.
Brandes, Alba A., Francesca Vastola, Umberto Basso, et al.. (2002). Temozolomide in Glioblastoma Multiforme of the Elderly. Tumori Journal. 88(1_suppl1). S69–S70.
13.
Brandes, Alba A., Lara Maria Pasetto, Francesca Vastola, & S. Monfardini. (2000). Temozolomide in Patients with High Grade Gliomas. Oncology. 59(3). 181–186. 22 indexed citations
14.
Brandes, Alba A., Francesca Vastola, & S. Monfardini. (1999). Reoperation in Recurrent High-Grade Gliomas. American Journal of Clinical Oncology. 22(4). 387–390. 21 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026